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Abstract
The Hepatitis C virus (HCV) has developed a small membrane protein, p7, which remarkably can
self-assemble into a large channel complex that selectively conducts cations1-4. We are curious as
to what structural solution has the viroporin adopted to afford selective cation conduction because
p7 has no homology with any of the known prokaryotic or eukaryotic channel proteins. The p7
activity can be inhibited by amantadine and rimantadine2,5, which also happen to be potent
blockers of the influenza M2 channel6 and licensed drugs against influenza infections7. The
adamantane derivatives were subjects of HCV clinical trials8, but large variation in drug efficacy
among the various HCV genotypes has been difficult to explain without detailed molecular
structures. Here, we determined the structures of this HCV viroporin as well as its drug-binding
site using the latest nuclear magnetic resonance (NMR) technologies. The structure exhibits an
unusual mode of hexameric assembly, where the individual p7 monomers, i, not only interact with
their immediate neighbors, but also reach farther to associate with the i+2 and i+3 monomers,
forming a sophisticated, funnel-like architecture. The structure also alludes to a mechanism of
cation selection: an asparagine/histidine ring that constricts the narrow end of the funnel serves as
a broad cation selectivity filter while an arginine/lysine ring that defines the wide end of the funnel
may selectively allow cation diffusion into the channel. Our functional investigation using whole-
cell channel recording showed that these residues are indeed critical for channel activity. NMR
measurements of the channel-drug complex revealed six equivalent hydrophobic pockets between
the peripheral and pore-forming helices to which amantadine or rimantadine binds, and compound
binding specifically to this position may allosterically inhibit cation conduction by preventing the
channel from opening. Our data provide molecular explanation for p7-mediated cation
conductance and its inhibition by adamantane derivatives.
Correspondence and requests for materials should be addressed to J.J.C. (chou@cmcd.hms.harvard.edu) and B.S. (bsun@sibs.ac.cn).
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tMany viruses have developed integral membrane proteins to transport ions and other
molecules across the membrane barrier to aid various steps of viral entry and maturation9,10.
These membrane structures, known as viroporins, usually adopt minimalist architectures that
are significantly different from those of bacterial or eukaryotic ion channels. Therefore,
understanding the structural basis of how viroporins function broadens our knowledge of
channels and transporters while generating new opportunities for therapeutic intervention.
The viroporin formed by the HCV p7 protein has been sought after as potential anti-HCV
drug target5,11. p7 is a 63-residue membrane protein that oligomerizes to form ion channels
with cation selectivity, for Ca2+ over K+ and Na+2,3,12,13, and more recent studies also
reported p7-mediated H+ intracellular conductance14. The p7 channel is required for viral
replication15; it has been shown to facilitate efficient assembly and release of infectious
virions16,17, though the precise mechanism of these functions remains unclear. The channel
activity can be inhibited by adamantane and long alkylchain iminosugar derivatives and
hexamethylene amiloride in vitro, with varying reported efficacies2,3,12,13. In addition to ion
conduction, p7 has been shown to specifically interact with the non-structural HCV protein
NS2, suggesting that its channel activity could be regulated18,19.
There is not yet a detailed structure of the p7 channel, though a number of pioneering NMR
studies showed that the p7 monomer has three helical segments: two in the N-terminal half
of the sequence and one near the C-terminus12,20. A single-particle electron microscopy
(EM) study obtained a 16 Å resolution electron density map of the p7 oligomer using the
random conical tilting approach4. The map shows that the p7 channel is a 42 kDa hexamer
and adopts a flower-like shape that does not resemble any of the known ion channel
structures in the database.
How does the small p7 polypeptide assemble into what appears to be a complex channel
structure? Has the viroporin adopted novel structural elements for cation selectivity and
channel gating? Amantadine or rimantadine blocks the influenza M2 channel by binding to
the small pore formed by four transmembrane helices21-23, but the pore of the p7 hexamer is
expected to be much bigger and it is thus unclear how would these small molecules fit. We
sought to address these important questions by determining detailed structures of the p7
hexamer and its drug-binding site.
We systematically tested p7 amino acid sequences from various HCV genotypes and found
that the sequence from genotype 5a (EUH1480 strain) generated samples that were
sufficiently soluble for structure determination (Supplementary Fig. 1). This p7 construct,
designated here as p7(5a), could be efficiently reconstituted in dodecylphosphocholine
(DPC) micelles at near physiological pH and generated high quality NMR spectra
(Supplementary Fig. 2). Negative-stain EM of the DPC-reconstituted p7(5a) in NMR buffer
showed hexameric, flower-shaped particles that are similar to those in the electron
micrographs of the p7 (JFH-1 strain, genotype 2a) hexamer in dihexanoyl-phosphatidyl-
choline (DHPC) micelles used earlier for single-particle reconstruction4 (Supplementary
Fig. 3). Moreover, isothermal titration calorimetry and NMR chemical shift perturbation
analyses of p7(5a)-rimantadine interaction showed that the drug binds specifically to the
reconstituted protein with a binding constant (Kd) from 50-100 μM at 3 mM detergent
concentration (Supplementary Fig. 4&5). The above results together indicate that the p7(5a)
polypeptides reconstituted in DPC micelles form structurally relevant hexamers.
Structure determination of the p7(5a) hexamer by NMR employed approach taken earlier for
oligomeric membrane proteins24-26, which involves 1) determination of local structures of
the monomers and 2) assembly of the oligomer with intermonomer distance restraints and
orientation constraints. The NMR-derived restraints define an ensemble of structures with
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tbackbone r.m.s. deviation of 0.74 Å (Fig. 1a). Each monomer consists of an N-terminal
helix (H1) from residues 5-16, a middle helical segment (H2), with a kink at Gly34, from
residues 20-41, and a C-terminal helix (H3) from residues 48-58. These secondary structures
are consistent with earlier NMR studies of p7 monomers in DHPC detergent and organic
solvent12,20. There are no intramonomer contacts (Fig. 1a). The monomers are intertwined
to form a tightly packed channel, where H1 and H2 form the channel interior and H3 is
lipid-facing and packs against H2 of the i+2 and H1 of the i+3 monomer (Fig. 1a&b). The
intermonomer association between H3 and H2 appears to be stabilized by interaction
involving conserved residues such as Trp30, Tyr42, and Leu52, and the contacts between
H3 and H1 are mostly between the alanine rich region of H1 (residues 10-15) and Ala61 and
Ala63 of H3 (Fig. 1c). The overall structure of the p7(5a) hexamer has a flower-like shape
that agrees with the EM map (EM database ID:1661), fitting to the map with a correlation
coefficient of 0.94 (Fig. 1d).
The channel cavity has a funnel profile that resembles a champagne flute and is largely
hydrophilic (Fig. 2a). The H2 helices form the wide cylindrical region (internal diameter,
I.D. ~12 Å) by packing with each other at large angles (angle between adjacent helices ~
-47°), and the H1 helices assemble at smaller packing angles (~ -34°) to form the narrow
conical region of the funnel (smallest I.D. at 6.8 Å). Residues 17-19 constitute the flexible
joint between H1 and H2; their NMR resonances are significantly broader than other regions
of the protein, suggesting the presence of conformational exchange.
The channel architecture described above represents a novel topology and exemplifies how
HCV has optimized the short p7 polypeptide to achieve a rather complex channel structure.
What are then the elements for cation conduction and gating? An in-depth examination of
the channel interior found two strongly conserved polar residues with salient structural
features (Fig. 2b). One is Asn9, which forms a ring of carboxamide that constricts the
conical region of the channel (Fig. 2c). Residue 9 is asparagine in all strains except being
substituted with histidine in genotype 2 viruses. Both asparagines and histidines have
affinity for monovalent and divalent cations. We hypothesize that the Asn9 ring serves as a
broad selectivity filter that dehydrates cations, allowing them to pass the hydrophobic ring
formed by Ile6. The Ile6 ring defines the narrowest point of the channel and likely serves as
a hydrophobic gate. Another feature is the Arg35 ring that defines the wider, C-terminal end
of the channel (Fig. 2b). Placement of a positively charged ring on the other end of the pore
was incomprehensible to us initially because it can repel cations. But the recent structure of
an Orai Ca2+ channel also revealed a stretch of basic residues in the ion conducting pore27.
We hypothesize that one of the Arg35 roles is to bind and obstruct anions at the pore
entrance while allowing cations to diffuse into the pore. In this model, cation conduction is
unidirectional from the C- to N-terminal end of the channel.
To test the above hypotheses, we established an assay that uses the two-electrode voltage-
clamp technique to record p7-mediated current in Xenopus oocytes (METHODS). Due to the
poor stability of oocytes that overexpress p7(5a), p7 (JFH-1 strain, genotype 2a) was used
instead for these experiments. As expected of the proposed role of residue 9 in selectively
dehydrating cations, replacing His9 of p7(2a) with alanine caused ~70% reduction in
channel conductance at +80 mV (Fig. 2d). The proposed role of Arg35 infers that placing
negatively charged residues at the channel entrance would bind cations and hinder their
diffusion into the pore, and indeed the R35D mutation also reduced conductance by ~70%
(Fig. 2d).
We next investigated the mechanism of amantadine binding to the p7 channel using proteins
that are 15N-labeled and deuterated so that Nuclear Overhauser Enhancement (NOE)
between the protein backbone amide protons and drug protons could be measured
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tunambiguously. At 10 mM amantadine (not corrected for drug partitioning to detergent
micelles), the 15N-edited NOESY spectrum showed NOE crosspeaks between the
adamantane protons and the amide protons of Val26, Leu55, Leu56, and Arg57 (Fig. 3a).
We then identified contacts between the drug and protein sidechains using protein that is
(1H/13C)-labeled at the methyl positions of alanines, valines and leucines but is otherwise
deuterated. In this case, the 13C-edited NOESY showed several methyl-drug NOEs (Fig.
3b).
These NOEs were used to dock amantadine into the structure determined in the absence of
drug. In doing so, we emphasize that the relevance of the p7-amantadine complex is
confined to only the drug binding region because we do not know how and to what degree
does drug binding alter the global conformation of the channel. The relatively poor stability
of the protein-drug complex at the current stage of our study precludes full-scale structure
determination. Nonetheless the available NMR data show that the drug adamantane binds to
six equivalent hydrophobic pockets between the pore-forming and peripheral helices (Fig.
3c). The pocket consists of Leu52, Val53, and Leu56 from H3, and Phe20, Val25, and Val26
from H2. The amantadine amino group on average points to the channel lumen. The same
NOESY spectrum as above recorded using a sample with 5 mM rimantadine indicates that
rimantadine binds to the same pocket with the methyl and amino groups pointing to the
lumen (Supplementary Fig. 6).
The binding site is overall consistent with mutational study showing that mutations in
residues 50-55 significantly reduced drug sensitivity of the channel28. It is also consistent
with a L20F mutation in genotype 1b virus originally identified in clinical trials that confers
amantadine resistance8,29. In the p7(5a) structure, residue 20 is an integral part of the drug
pocket and is in direct contact with the drug adamantane. Therefore, replacing Leu20 in
p7(1b) with phenylalanine is expected to reduce hydrophobic interaction with the drug.
Elucidation of previous functional data in the context of the structure suggests that the
binding site shown in Fig. 3c is relevant to drug inhibition and that interactions between the
drug adamantane and protein hydrophobic residues are critical for inhibition. Variations in
the hydrophobicity of the binding pocket among the p7 variants (Supplementary Fig. 7) thus
explain the large differences in drug efficacies observed between different HCV genotypes.
We have learnt from KcsA and other channels that a gated ion channel generally adopts two
essential features: pore elements that provide ion selectivity and gating mechanism that can
transiently open the channel to allow ion permeation. By virtue of being a funnel, the p7
structure suggests that the tip of the funnel represented by the Ile6 and Asn9 rings is the key
region for channel gating (Fig. 4). The role of the Asn9 ring is to provide ion selectivity by
recruiting and dehydrating cations near the funnel exit, whereas the Ile6 ring is a
hydrophobic constriction that would prevent water from freely passing through. Channel
activation may involve reorientation of the H1 helices that widens the funnel tip, analogous
to the dynamic C-terminal helix of KcsA30, and such structural rearrangement can be
afforded by the flexible hinge between H1 and H2, the intervening loop between H2 and H3,
and the C-terminal tail that “latches” onto H1. We thus propose that binding of adamantane
derivatives inhibit channel activity by restricting the structural rearrangement. Our NMR
titration data (Supplementary Fig. 5c) is consistent with this proposal, which showed that in
the absence of rimantadine, the Ile6 methyl resonance is split into an intense and weak peak,
possibly corresponding to the open and closed state, respectively, and that increasing the
drug concentration shifted the equilibrium that made the weak peak stronger. Although
rigorous testing of the model is needed, the preliminary observation suggests the existence
of multiple states of the p7 channel.
OuYang et al. Page 4
Nature. Author manuscript; available in PMC 2013 December 27.
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
t
N
I
H
-
P
A
 
A
u
t
h
o
r
 
M
a
n
u
s
c
r
i
p
tMETHODS
Sample Preparation
The amino acid sequence of p7 from genotype 5a was slightly modified to allow for efficient
reconstitution and protein sample stability. In this sequence, Thr1 is replaced with Gly,
Ala12 is replaced with Ser, and the three cysteines at positions 2, 27, and 44 are replaced
with Ala, Thr, and Ser, respectively (Supplementary Fig. 1). The p7(5a) construct was
cloned, expressed and purified as previously described1,2. Briefly, the protein was expressed
as a fusion to His9–trpLE that formed inclusion bodies. The peptide was released from the
fusion protein by CNBr digestion and subsequently separated on a Proto-18C column by
reverse-phase chromatography (more details given in Supplementary Methods). The
lyophilized peptide was then dissolved in 6 M guanidine and DPC and refolded by dialysis
against the NMR buffer. A typical NMR sample contains 0.8 mM protein (monomer
concentration), 200 mM DPC, and 25 mM MES (pH 6.5).
Assignment of NMR resonances
All NMR experiments were conducted at 30 °C on Bruker spectrometers equipped with
cryogenic probes. Sequence specific assignment of backbone chemical shifts was
accomplished using three pairs of triple resonance experiments, recorded using
a 15N/13C/2H labeled sample. The triple resonance experiments were relaxation optimized
(TROSY)3, including HNCA, HN(CO)CA, HNCACB, HN(CO)CACB, HN(CA)CO, and
HNCO4. Protein sidechain aliphatic and aromatic resonances were assigned using a
combination of NOESYs including 15N-edited NOESY-TROSY (60 ms NOE mixing time,
τNOE) and 13C-edited NOESY-HSQCs (τNOE=100 ms). Specific stereo assignment of the
methyl groups of valines and leucines were obtained from a constant-time 1H-13C HSQC
spectrum recorded using a 15% 13C-labeled sample5.
Assignment of local NOEs for determining the secondary structures
The same 15N-edited NOESY-TROSY and 13C-edited NOESY-HSQC above with short
τNOE were used to assign local NOEs. Combining the NOE restraints with chemical shifts,
we could very precisely define the helical and loop regions of the individual monomers.
Measurement of residual dipolar coupling (RDC) constants
The backbone 1H-15N RDCs were measured using a modified approach6 of the strain-
induced alignment in a gel method7,8. In this experiment the p7(5a) channel in DPC micelles
was soaked into a cylindrically shaped polyacrylamide gel (4.5%), initially of 6 mm
diameter, which was subsequently radially compressed to fit within the 4.2 mm inner
diameter of an open-ended NMR tube. The 1H-15N RDCs were obtained from 1JNH/2 and
(1JNH+1DNH)/2, which were measured by interleaving a regular gradient-enhanced HSQC
and a gradient-selected TROSY9. The largest 1H-15N RDC measured is 33.5 Hz.
Assignment of intermonomer NOEs
Intermonomer NOEs between protein backbone amide and sidechain methyl protons was
assigned using a sample that was reconstituted with a 1:1 mixture of 15N-, 2H-labeled p7(5a)
peptide and 13C-labeled peptide. Recording a 15N-edited NOESY-TROSY (τNOE=300 ms)
on a 900 MHz spectrometer with this sample allowed exclusive detection of NOE
crosspeaks between the 15N-attached protons of one monomer and the 13C-attached protons
of other monomers. The intermonomer NOEs between the neighboring H1 helices and
neighboring H2 helices effectively defined the central cavity formed by these helices. The
initial structural solution of the pore assembly then allowed us to assign complementary and
self-consistent intermonomer NOEs between the aliphatic and aromatic protons in a pair
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tof 15N-edited NOESY-TROSY and 13C-edited NOESY-HSQC recorded using a 15N-, 13C-
labeled sample. These spectra were recorded with τNOE of 120 ms and 150 ms, respectively.
The packing of H1 and H2 helices between the adjacent monomers and RDC-derived
orientation constraints together positioned the H3 helix of monomer i to be in contact with
H2 of the i+2 and H1 of the i+3 monomers, and this conformation was confirmed by the
unambiguous amide-methyl NOEs between H3 and H1/H2. The conformation as defined by
the intermonomer NOEs was subject to numerous rounds of self-consistency test with the
NOE crosspeaks in the 13C-edited NOESY-HSQC spectrum to ensure that all NOEs are
consistent with the structure. The overall distribution of intermonomer NOEs is illustrated in
Supplementary Fig. 7.
Assignment of NOEs between protein and drug
We prepared a sample containing 15N-, 2H-labeled p7(5a), 10 mM amantadine (or 5 mM
rimantadine), and perdeuterated DPC. The sample was used to record a 15N-edited NOESY-
TROSY (τNOE=300 ms) on a 900 MHz spectrometer. This experiment allowed exclusive
detection of NOEs between the exchangeable amide protons and the drug protons. For
assigning NOEs between the protein sidechain methyl protons and the drug protons, we
prepared the ALV-labeled protein that is 1H-, 13C-labeled at the methyl positions of
alanines, valines and leucines but is otherwise deuterated. The NOEs were measured using
a 13C-edited NOESY with diagonal suppression, i.e., interleaving two experiments: one with
NOE mixing (300 ms) of the Hz magnetization (NOE crosspeaks) and the other with mixing
of the HzCz magnetization (no NOE crosspeaks)10. Subtracting the two spectra mostly
cancelled the strong methyl diagonal peaks (~0.8 ppm) and thereby unveiled the weak
methyl-drug NOEs at ~1.7 ppm.
Structure calculation of the p7(5a) hexamer
Structures were calculated using the program XPLOR-NIH11. The monomer structures
(mainly the secondary structures) were first calculated using intramonomer NOE-derived
distance restraints, backbone dihedral restraints derived from chemical shifts using the
TALOS program12, and RDC restraints. A total of 10 monomer structures were calculated
using a standard simulated annealing (SA) protocol. Six copies of the lowest-energy
monomer structure were used to construct an initial model of the hexamer using
intermonomer NOE restraints collected from the mixed-labeled sample for the H1 and H2
helical segments. For each intermonomer restraint between two adjacent monomers, six
identical distance restraints were assigned respectively to all pairs of neighboring monomers
to satisfy the condition of C6 rotational symmetry (as indicated by the EM data). The
assembled hexamer was then subject to refinement against RDCs to accurately orient the
three helical segments. Finally, using the SA protocol, the hexamer was refined against the
complete set of NOE restraints (including intramonomer and intermonomer distance
restraints), dihedral restraints, and RDC restraints. A total of 60 hexamer structures were
calculated and 15 low energy structures were selected as the structural ensemble.
Ramachandran plot statistics for the structure ensemble, calculated using PROCHECK13,
are as follows: most favored (96.6%), additionally allowed (2.8%), generously allowed
(0.6%) and disallowed (0.0%).
Whole-cell channel recording assay for p7
The cRNA of p7(2a) variants were synthesized and injected into Xenopus laevis oocytes at
~15 ng per oocyte. After about 16-30 hours of expression, healthy oocytes were collected
and subject to channel recording using the two-electrode voltage-clamp technique14. The
oocytes were first bathed in standard ORi solution (90 mM NaCl, 2 mM KCl, 2 mM CaCl2,
and 5 mM MOPS, pH 7.4) before impaled with two microelectrodes. For recording p7-
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tmediated current, we used a voltage-clamp protocol consisting of rectangular voltage steps
from −100 to +80 mV in 10 mV increments, applied from a holding voltage of −60 mV.
Expression levels of the p7 variants in oocytes were examined by confocal microscopy using
HA-tagged p7. More experimental details are described in Supplementary Methods.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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tFigure 1. NMR structure of the p7(5a) hexamer and its comparison to the EM map
a, Ensemble of 15 low-energy structures calculated using NMR restraints summarized in
Supplementary Table 1. b, Two-dimensional drawing illustrating the intermonomer
interactions among the H1, H2, and H3 helical segments that are responsible for the
hexameric assembly. c, Three-dimensional cartoon representation describing the global
arrangement of helical segments and amino acids that appear to play a role in the packing of
H3 against H1 and H2. d, Fitting the lowest energy structure from the ensemble to the 16 Å
EM map (EM database ID:1661)4. The fitting correlation is 0.94 as calculated with the
program Chimera.
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tFigure 2. The pore properties of the p7(5a) channel
a, The pore surface calculated using the program HOLE, showing the shape and
constrictions of the pore. b, Sectional view of the channel showing the pore-lining residues
with residues in red being strongly conserved. The numbers next to the helical segments
represent the monomers to which the helices belong. c, A close view of the rings formed by
Asn9 and Ile6 that constrict the N-terminal end of the channel. d, The current-voltage
relationships of wildtype p7(2a) and the H9A and R35D mutants. Each data point is the
mean ± SEM (standard error of mean) calculated over measurements from six different
oocytes (n=6).
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tFigure 3. NMR characterization of the amantadine binding site
a, Representative strips from the 3D 15N-edited NOESY-TROSY spectrum (300 ms NOE
mixing time) recorded using a sample containing 15N-, 2H-labeled p7(5a) and 10 mM
amantadine, showing amantadine NOEs to the backbone amide protons of Val26, Leu55,
Leu56, and Arg57. b, Representative strips from the 3D diagonal-suppressed 13C-edited
NOESY-HSQC spectrum recorded using a sample that is 1H-, 13C-labeled at the methyl
positions of alanines, valines and leucines but is otherwise deuterated, showing drug NOEs
to the sidechain methyl protons of Val26, Leu52, and Val53. The spectra in a and b were
recorded at 1H frequency of 900 MHz. c, Amantadine docked into the p7(5a) hexamer using
restraints from NOEs in a and b (left) and a close view of amantadine in the binding pocket
(right).
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tFigure 4. A model for amantadine or rimantadine inhibition of the p7 channel
The two-dimensional cartoon drawing mimics the sectional view of the p7 channel in Fig.
2b. The channel undergoes conformational switching between the closed and the open states
but favors the open state in the presence of cations (blue circles). Binding of amantadine or
rimantadine (green circle) favors the closed state by restricting movements of the three
helical segments that may be required for channel opening.
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